Philip Morris delivered strong Q4 results, surpassing EPS and revenue estimates, driven by surging demand for non-traditional products like IQOS and ZYN. Non-traditional products now represent 40% ...

Philip Morris continues to see solid growth led by Zyn. It has a big opportunity in a few years with its IQOS product in the U.S. The stock is attractively valued and still has a nice dividend yield.

Philip Morris International PM0.96%increase; green up pointing triangle posted higher-than-expected revenue in its fourth quarter, signaling its Zyn nicotine pouches continue to power results.

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

(Reuters) -Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with estimations for its fast-growing nicotine pouch brand ZYN also ahead ...

Cigarette giant Philip Morris International (PM.N), opens new tab on Thursday forecast better-than-expected profit growth for 2025, with estimations for its fast-growing nicotine pouch brand ZYN ...

(Bloomberg) — Philip Morris International Inc. soared to a record after reporting better-than-expected profit driven by sales of Zyn nicotine pouches. The tobacco maker, which sells Marlboro ...

Overall, the quarter highlighted Philip Morris's strategic shift towards smoke ... boosting its portfolio with the ZYN brand. This investment is part of a broader strategy to expand the ...

Philip Morris International posted higher-than-expected revenue in its fourth quarter, signaling its Zyn nicotine pouches continue to power results higher. The tobacco company logged operating ...